The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Transport of 5-aminolevulinic acid between blood and brain
Abstract
Little is known about the movement of 5-aminolevulinic acid (delta-aminolevulinic acid; ALA) between blood and brain. This is despite the fact that increases in brain ALA may be involved in generating the neuropsychiatric symptoms in porphyrias and that systemic administration of ALA is currently being used to delineate the borders of malignant gliomas. The current study examines the mechanisms involved in the movement of [(14)C]ALA across the blood-brain and blood-CSF barriers in the rat. In the adult rat, the influx rate constant (K(i)) for [(14)C]ALA movement into brain was low ( approximately 0.2 microl/g per min), was unaffected by increasing plasma concentrations of non-radioactive ALA or probenecid (an organic anion transport inhibitor) and, therefore, appears to be a diffusional process. The K(i) for [(14)C]ALA was 3-fold less than that for [(14)C]mannitol, a molecule of similar size. This difference appears to result from a lower lipid solubility rather than saturable [(14)C]ALA transport from brain to blood. The K(i) for [(14)C]ALA for uptake into the neonatal brain was 7-fold higher than in the adult. However, again, this was unaffected by increasing plasma ALA concentrations suggesting a diffusional process. In contrast, at the blood-CSF barrier, there was evidence of carrier-mediated [(14)C]ALA transport from blood to choroid plexus and blood to CSF. Both processes were inhibited by administration of non-radioactive ALA and probenecid. However, experiments in choroid plexus epithelial cell primary cultures indicated that transport in these cells was polarized with [(14)C]ALA uptake from the apical (CSF) side being about 7-fold greater than uptake from the basolateral (blood) side. In total, these results suggest that the brain is normally fairly well protected from changes in plasma ALA concentration by the very low blood-brain barrier permeability of this compound and by a saturable efflux mechanism present at the choroid plexus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALA has a low permeability across the BBB that protects the brain from the entry of unwanted endogenous and exogenous chemicals [54].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [54]
In the citing paper
“It should be mentioned that ALA can still cross the BBB into the brain through a slow diffusional process [54].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [54]
Citations
Cites
Walter, S., Susanne, S., Simon, W., Herbert, S., Clemens, F., Claudia, G., Alwin, E. G., Rainer, K., & Hans, J. R. (1998) · Neurosurgery · doi:10.1097/00006123-199803000-00017 · Cited by 690
Transport of α-Aminoisobutyric Acid across Brain Capillary and Cellular Membranes
Blasberg, R. G., Fenstermacher, J. D., & Patlak, C. S. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.2 · Cited by 517
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 454
Stummer, W., Stepp, H. G., Möller, G., Ehrhardt, A., Leonhard, M., & Reulen, H.-J. (1998) · Acta Neurochirurgica · doi:10.1007/s007010050206 · Cited by 282
Self-citationDöring, F., Walter, J., Will, J., Föcking, M., Boll, M., Amasheh, S., Clauss, W. G., & Daniel, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1909 · Cited by 269
Stummer, W., Stocker, S., Novotny, A., Heimann, A., Sauer, O., Kempski, O. S., Plesnila, N., Wietzorrek, J., & Reulen, H.-J. (1998) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(98)00176-6 · Cited by 253
Self-citationStrazielle, N., & Ghersi‐Egea, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06275.1999 · Cited by 184
Demasi, M., Penatti, C. A. A., DeLucia, R., & Bechara, E. J. H. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02035-7 · Cited by 112
Mechanisms of 5‐Aminolevulinic Acid Uptake at the Choroid Plexus
Novotny, A., Xiang, J., Stummer, W., Teuscher, N. S., Smith, D. E., & Keep, R. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750321.x · Cited by 107
Self-citationShu, C., Shen, H., Teuscher, N. S., Lorenzi, P. J., Keep, R. F., & Smith, D. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.820 · Cited by 102
Self-citation
Cited by
Sorted by citations
Hadjipanayis, C. G., Widhalm, G., & Stummer, W. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000929 · Cited by 385
Self-citation5‐ALA in the management of malignant glioma
Stepp, H., & Stummer, W. (2018) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22933 · Cited by 234
Self-citationFIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS
Nabavi, A., Thurm, H. C., Zountsas, B., Pietsch, T., Lanfermann, H., Pichlmeier, U., & Mehdorn, H. M. (2009) · Neurosurgery · doi:10.1227/01.neu.0000360128.03597.c7 · Cited by 201
Bisland, S. K., Lilge, L., Lin, A., Rusnov, R., & Wilson, B. C. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-03-05-ra-100.1 · Cited by 173
Teng, L., Nakada, M., Zhao, S.-G., Endo, Y., Furuyama, N., Nambu, E., Pyko, I. V., Hayashi, Y., & Hamada, J.-I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.12 · Cited by 172
Metadata
- Authors
- Ennis, S. R., Novotny, A., Xiang, J., Shakui, P., Masada, T., Stummer, W., Smith, D. E., & Keep, R. F.
- Affiliations
- University of Michigan (US)
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Keep, R.F
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 959
- Issue
- 2
- Pages
- 226-234
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2063825033
- Cited by
- 146
- References
- 31
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 4 · 2022: 10 · 2021: 11 · 2020: 9 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 6
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL018575)
- National Institute of General Medical Sciences (R01GM035498)
- National Institute of Neurological Disorders and Stroke (R01NS034709)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- 5-aminolevulinic acid, blood-brain barrier permeability, blood-CSF barrier, choroid plexus, diffusion, probenecid, neonatal brain, porphyria, choroid plexus epithelial cells, lipid solubility
- MeSH terms
- Aminolevulinic Acid, Animals, Biological Transport, Blood-Brain Barrier, Cerebral Cortex, Kidney, Rats, Inbred F344, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
